Candida endophthalmitis in non-neutropenic critically ill patients

Area of Science:

• Infectious Diseases
• Ophthalmology
• Critical Care Medicine

Background:

• Hematogenous endophthalmitis is a severe ocular complication.
• Candida species are a significant cause of bloodstream infections in critically ill patients.
• Early diagnosis and treatment are vital for visual outcomes and survival.

Purpose of the Study:

• To investigate the incidence and characteristics of hematogenous endophthalmitis in critically ill patients with candidemia.
• To assess the clinical presentation and outcomes of Candida endophthalmitis.
• To evaluate the role of early ophthalmoscopic examination and antifungal therapy.

Main Methods:

• Prospective study of six non-neutropenic critically ill patients with hematogenous endophthalmitis.
• Blood cultures were used to identify Candida species.
• Ophthalmoscopic examinations were performed.
• Treatment with fluconazole was administered in some cases.

Main Results:

• The incidence of endophthalmitis in patients with candidemia was 13%.
• Candida albicans was the predominant species identified.
• All patients had positive blood cultures for Candida.
• Fluconazole efficacy could not be fully evaluated due to patient mortality.

Conclusions:

• Critically ill patients with candidemia are at risk for developing hematogenous endophthalmitis.
• Regular ophthalmoscopic examinations are recommended for early detection.
• Prompt initiation of systemic antifungal therapy is crucial for managing Candida endophthalmitis in at-risk populations.